Journal of Experimental and Clinical Cancer Research

SJR Rank #490H-index: 152SJR: 3.731Best quartile: Q1Open AccessAPC: US$4,190Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.951.92.853.8

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer-related molecular mechanisms researchMicroRNA in disease regulationCancer Cells and MetastasisCancer, Hypoxia, and MetabolismCircular RNAs in diseasesFerroptosis and cancer prognosisImmune cells in cancerCancer Immunotherapy and BiomarkersRNA modifications and cancerEpigenetics and DNA Methylation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

20222025085170255340

Detailed Information

ISSN

1756-9966, 0392-9078

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

11.75

References per Document

68.83

Coverage

1982-2026

Scope

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside. Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer. Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.

Metrics from SCImago Journal Rank 2025. View on SCImago